- Joined
- May 29, 2004
- Messages
- 463
- Reaction score
- 1
This is #143
Basically,
The explanation says: IGF-1 is structurally similar to insulin. Since structurally similar molecules often share receptors, it can be assumed IGF-1 can bind to insulin receptors.
Is this really a safe assumption? I mean, some enantiomers that's almost identical to each other can't fit into each other's receptors.
Basically,
The explanation says: IGF-1 is structurally similar to insulin. Since structurally similar molecules often share receptors, it can be assumed IGF-1 can bind to insulin receptors.
Is this really a safe assumption? I mean, some enantiomers that's almost identical to each other can't fit into each other's receptors.